Production of novel ebola virus-like particles from cDNAs: an alternative to ebola virus generation by reverse genetics.
about
Emerging targets and novel approaches to Ebola virus prophylaxis and treatmentEbolavirus is internalized into host cells via macropinocytosis in a viral glycoprotein-dependent mannerCrystal structure of the C-terminal domain of Ebola virus VP30 reveals a role in transcription and nucleocapsid associationA small stem-loop structure of the Ebola virus trailer is essential for replication and interacts with heat-shock protein A8Assembly and budding of Ebolavirus.Mapping of the VP40-binding regions of the nucleoprotein of Ebola virus.A replication-incompetent Rift Valley fever vaccine: chimeric virus-like particles protect mice and rats against lethal challengeCharacterization of Ebolavirus regulatory genomic regions.Role of Ebola virus secreted glycoproteins and virus-like particles in activation of human macrophagesEbola Vaccine: How Far are we?Ebola virus VP40 late domains are not essential for viral replication in cell cultureMinigenome-based reporter system suitable for high-throughput screening of compounds able to inhibit Ebolavirus replication and/or transcription.Oligomerization of Ebola virus VP40 is essential for particle morphogenesis and regulation of viral transcriptionA novel life cycle modeling system for Ebola virus shows a genome length-dependent role of VP24 in virus infectivityDual selection mechanisms drive efficient single-gene reverse genetics for rotavirusAntagonism of type I interferon responses by new world hantavirusesFilovirus replication and transcription.Treatment of ebola virus disease.Functional mapping of the nucleoprotein of Ebola virus.An upstream open reading frame modulates ebola virus polymerase translation and virus replication.Ebola virus VP24 binds karyopherin alpha1 and blocks STAT1 nuclear accumulationReverse genetic generation of recombinant Zaire Ebola viruses containing disrupted IRF-3 inhibitory domains results in attenuated virus growth in vitro and higher levels of IRF-3 activation without inhibiting viral transcription or replication.Infection of naive target cells with virus-like particles: implications for the function of ebola virus VP24.Antiviral Decoction of Isatidis Radix ( bǎn lán gēn) Inhibited Influenza Virus Adsorption on MDCK Cells by Cytoprotective Activity.Contribution of Sec61α to the life cycle of Ebola virus.The Ebolavirus VP24 protein blocks phosphorylation of p38 mitogen-activated protein kinase.sGP serves as a structural protein in Ebola virus infection.A virus-like particle system identifies the endonuclease domain of Crimean-Congo hemorrhagic fever virus.The role of antigen-presenting cells in filoviral hemorrhagic fever: gaps in current knowledge.Genus-specific recruitment of filovirus ribonucleoprotein complexes into budding particlesProgress in filovirus vaccine development: evaluating the potential for clinical use.Filovirus-like particles as vaccines and discovery tools.Survey and Visual Detection of Zaire ebolavirus in Clinical Samples Targeting the Nucleoprotein Gene in Sierra Leone.Inhibition of Marburg virus budding by nonneutralizing antibodies to the envelope glycoprotein.Ebola virus matrix protein VP40 uses the COPII transport system for its intracellular transport.Minigenomes, transcription and replication competent virus-like particles and beyond: reverse genetics systems for filoviruses and other negative stranded hemorrhagic fever virusesModeling the lifecycle of Ebola virus under biosafety level 2 conditions with virus-like particles containing tetracistronic minigenomes.DNA topoisomerase 1 facilitates the transcription and replication of the Ebola virus genome.Identification of functional domains in reovirus replication proteins muNS and mu2.The marburg virus 3' noncoding region structurally and functionally differs from that of ebola virus.
P2860
Q24597625-EADC1CA8-AD45-451A-B4F6-76798C309DEDQ27313378-71B8FCB1-CC5B-4ED7-B11C-0BBB013FF309Q27641049-F85C73E8-AFAD-41B3-BF46-8981145BB197Q28396935-3D6D4037-9951-4ABE-8230-EBE89ED6C09AQ33258817-D3349DFF-79D3-433F-AB3F-D23AE38D7B0EQ33269507-D1CDAF0B-4F64-47C3-ABB4-F55340655370Q33621078-53F84C3B-BBC2-454B-8B8C-65CA09EC1130Q33752402-05AF0D87-7F13-4618-843D-06EEAAC7A745Q33781224-0C73166D-2605-4B18-958C-ED51EC0E0437Q33831877-DB580B01-813D-4E34-9745-CFC50636D7B3Q33911884-08420EE9-EAD0-4427-A790-A14367BAF7B4Q33962901-8E4F923A-0F58-4F0C-AE4B-F328DDFDEED2Q33966568-7FAE197F-F9EC-41D8-A46D-A5BE656DDD61Q34262347-CCFA1B00-ADEE-428D-9838-8F29F2E5B725Q34276415-279A8C03-C51F-4230-9E33-AD3177D52481Q34296106-CED19D12-EE2C-4D77-A759-CCFA8FCE2B1DQ34375243-B9627372-1F0A-4EEF-8A1F-7B7F18BB8FA8Q34460182-A6056117-524B-4FBB-8D38-6E1F73E98AF6Q34545840-387F4652-FB96-4EAF-AA0B-4F92DC70396EQ34574867-C5BDBAD3-48C1-41F6-8161-817B31E5FEDBQ34648461-46D00F75-8E35-4265-81B8-8DE6F7E10CFCQ34717075-14C6F053-40D1-45BD-8155-B9E0C9C0DA70Q34717930-3177DD48-C1B9-4A1E-9EBB-179FCC07FCC4Q35143313-8187E9AA-65D6-4143-B4F7-EA4DF40E5292Q35299870-AF55BFA0-54D4-4E2C-9FB1-203B5901EBA2Q35299892-BBF58533-EEB3-4038-BEF8-8F7621A917ACQ35557177-F18C2C93-6156-4F39-97BC-4DA2EEC77149Q35587097-255FF975-BFEF-48EA-869E-3E08B55FFEF9Q35823426-399B823A-E64E-4678-B62E-EFD08599EE67Q35961320-FF79D6A3-A29D-414B-9AF8-A6E34A4FD338Q36100545-AB5936CF-5D61-43FB-BE0A-2DE52CFEF437Q36198685-899F6AA6-7522-480E-B9E8-0F97DC4C130DQ36332705-748CF72D-4BF4-41F4-B55B-F63F7CCFDA15Q36414333-95B1985D-A855-4F1F-955B-8280AFF9664AQ36580850-74C830A7-07AE-42C1-89EC-3ED42E49ACC8Q36650409-2A5897D8-3876-45FE-AB4A-32E4012B319DQ36788332-07ED0ADC-B363-4259-8F60-BB8CB65ADDE2Q37123264-9E105A0A-AD22-46B4-AA72-AB288A628F27Q37127878-7F2E801B-C8FC-4586-948C-75B4946AE0DEQ37157191-99D57A51-7CF8-4451-956C-7B647DF1E8BA
P2860
Production of novel ebola virus-like particles from cDNAs: an alternative to ebola virus generation by reverse genetics.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Production of novel ebola viru ...... eneration by reverse genetics.
@en
type
label
Production of novel ebola viru ...... eneration by reverse genetics.
@en
prefLabel
Production of novel ebola viru ...... eneration by reverse genetics.
@en
P2093
P2860
P1433
P1476
Production of novel ebola viru ...... eneration by reverse genetics.
@en
P2093
Ayato Takada
Luke D Jasenosky
Shinji Watanabe
Takeshi Noda
Tokiko Watanabe
P2860
P304
P356
10.1128/JVI.78.2.999-1005.2004
P407
P577
2004-01-01T00:00:00Z